Search

Search Results
Results 5381 - 5390 of 5416 for Activated state
  • New treatment options for leukemia and myeloproliferative disorders introduced
    News - 6 Dec 2009
    Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology introduces potential new...
  • Monoclonal antibody cancer therapy
    News - 6 Apr 2009
    The strategy of using monoclonal antibodies for cancer treatment was first described in the late 1970s with the promise that they could be developed into therapies that were highly specific to cancer...
  • Stress causes whole body deterioration
    News - 9 Jan 2008
    Stress, to put it bluntly, is bad for you. It can kill you, in fact. A study now reveals that stress causes deterioration in everything from your gums to your heart and can make you more susceptible...
  • M. D. Anderson wins $8.3-million to research environmental causes of major diseases
    News - 21 Apr 2007
    An $8.3-million federal grant to The University of Texas M. D. Anderson Cancer Center Science Park - Research Division addresses the complex interplay between such varied factors as genetics, diet,...
  • Turning the immune system against cancer
    News - 4 Aug 2006
    Medicine can now prevent a host of diseases with a mere shot of vaccine. Polio and smallpox are almost non-existent, and mumps and chicken pox are rarely seen nowadays.
  • World's first gene therapy trial aimed at preventing cancer
    News - 5 May 2004
    The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep...
  • Stelara
    Drug - 25 May 2026
    Consumer Medicine Information (CMI) about Stelara intended for persons living in Australia.
  • Three essential biomarkers for measuring immune activation
    White Paper - 20 Apr 2026
    Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and research applications.
  • The evolution of STEAP1 targeted therapy
    White Paper - 6 Jan 2026
    STEAP1 (Six-transmembrane epithelial antigen of the prostate 1), originally identified in prostate cancer, is a member of the STEAP protein family.
  • Cimzia
    Drug - 24 Nov 2025
    Consumer Medicine Information (CMI) about Cimzia intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback